- Home
- CDRE vs HROW Comparison
CDRE vs HROW Comparison
Compare CDRE & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDRE
- HROW
- Stock Information
- Founded
- CDRE 2012
- HROW 1998
- Country
- CDRE United States
- HROW United States
- Employees
- CDRE N/A
- HROW N/A
- Industry
- CDRE Industrial Specialties
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- CDRE Health Care
- HROW Health Care
- Exchange
- CDRE Nasdaq
- HROW Nasdaq
- Market Cap
- CDRE 1.3B
- HROW 1.1B
- IPO Year
- CDRE 2021
- HROW N/A
- Fundamental
- Price
- CDRE $29.24
- HROW $40.06
- Analyst Decision
- CDRE Buy
- HROW Strong Buy
- Analyst Count
- CDRE 2
- HROW 7
- Target Price
- CDRE $31.50
- HROW $64.67
- AVG Volume (30 Days)
- CDRE 384.5K
- HROW 613.8K
- Earning Date
- CDRE 08-05-2025
- HROW 08-11-2025
- Dividend Yield
- CDRE 1.29%
- HROW N/A
- EPS Growth
- CDRE N/A
- HROW N/A
- EPS
- CDRE 0.93
- HROW N/A
- Revenue
- CDRE $572,607,000.00
- HROW $227,661,000.00
- Revenue This Year
- CDRE $13.31
- HROW $46.17
- Revenue Next Year
- CDRE $7.96
- HROW $39.97
- P/E Ratio
- CDRE $31.57
- HROW N/A
- Revenue Growth
- CDRE 7.66
- HROW 47.69
- 52 Week Low
- CDRE $27.07
- HROW $20.85
- 52 Week High
- CDRE $40.28
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- CDRE 40.28
- HROW 64.97
- Support Level
- CDRE $28.22
- HROW $29.75
- Resistance Level
- CDRE $31.25
- HROW $38.15
- Average True Range (ATR)
- CDRE 1.54
- HROW 2.22
- MACD
- CDRE -0.36
- HROW 0.20
- Stochastic Oscillator
- CDRE 15.60
- HROW 93.45
About CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.